COVID-19 mRNA vaccine-mediated antibodies in human breast milk and their association with breast milk microbiota composition/Experiment 4

From BugSigDB


Reviewed Marked as Reviewed by ChiomaBlessing on 2024-2-15

Curated date: 2023/10/24

Curator: Folakunmi

Revision editor(s): Folakunmi, ChiomaBlessing

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Breast , Milk Mamma,Mammary part of chest,Mammary region,Breast,breast,Mammary gland milk,Milk,milk
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Response to vaccine Response to vaccine,response to vaccine
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Mothers at pre-vaccination timepoint (baseline)
Group 1 name Corresponds to the case (exposed) group for case-control studies
Mothers at one week post-first dose
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Breastfeeding mothers at one week after receiving the first dose of BNT162b2 vaccine.
Group 0 sample size Number of subjects in the control (unexposed) group
44
Group 1 sample size Number of subjects in the case (exposed) group
44
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
None

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
1.5

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Chao1 Abundance-based estimator of species richness
increased

Signature 1

Reviewed Marked as Reviewed by ChiomaBlessing on 2024-2-15

Curated date: 2023/10/24

Curator: Folakunmi

Revision editor(s): Folakunmi, ChiomaBlessing

Source: supplementary table 3

Description: differential abundance of mothers one week after first dose of BNT162b2 when compared to baseline.

Abundance in Group 1: increased abundance in Mothers at one week post-first dose

NCBI Quality ControlLinks
Acinetobacter radioresistens
Acinetobacter soli
Acinetobacter ursingii
Caldibacillus thermoamylovorans
Empedobacter brevis
Eubacterium ventriosum
Haemophilus haemolyticus
Haemophilus parahaemolyticus
Roseomonas gilardii
unclassified Actinobacillus
unclassified Anoxybacillus
unclassified Bacillus (in: firmicutes)
unclassified Bergeyella
unclassified Brevundimonas
unclassified Duganella
unclassified Empedobacter
unclassified Enhydrobacter
unclassified Flavobacterium
unclassified Janthinobacterium
unclassified Microbacterium
unclassified Paracoccaceae
unclassified Providencia
unclassified Pseudarthrobacter
unclassified Shewanella
unclassified Sphingomonadaceae
unclassified Sphingomonas
Clostridiales bacterium CHKCI001
unclassified Gordonia (in: high G+C Gram-positive bacteria)
unclassified Sphingobacterium
unclassified Allorhizobium-Neorhizobium Pararhizobium-Rhizobiumunclassified Allorhizobium-Neorhizobium Pararhizobium-Rhizobium

Revision editor(s): Folakunmi, ChiomaBlessing

Signature 2

Reviewed Marked as Reviewed by ChiomaBlessing on 2024-2-15

Curated date: 2024/02/15

Curator: ChiomaBlessing

Revision editor(s): ChiomaBlessing

Source: Supplementary Table 3

Description: Differential abundance of mothers one week after first dose of BNT162b2 when compared to baseline.

Abundance in Group 1: decreased abundance in Mothers at one week post-first dose

NCBI Quality ControlLinks
Acinetobacter baumannii
Lactobacillus intestinalis
unclassified Allobaculum
unclassified Bacilli
unclassified Comamonadaceae
unclassified Fusicatenibacter
unclassified Parabacteroides
unclassified Ralstonia
unclassified Turicibacter
unclassified Muribaculaceae

Revision editor(s): ChiomaBlessing